scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1034603304 |
P356 | DOI | 10.1038/SJ.ONC.1207359 |
P698 | PubMed publication ID | 14676827 |
P5875 | ResearchGate publication ID | 8958066 |
P2093 | author name string | Toivo Maimets | |
Sirle Laos | |||
Lilian Kadaja | |||
P2860 | cites work | Mechanisms of Cr(VI) induced p53 activation: the role of phosphorylation, mdm2 and ERK | Q23922086 |
Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome | Q24303591 | ||
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases | Q24319848 | ||
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways | Q24321528 | ||
A genetic model for colorectal tumorigenesis | Q27860582 | ||
p53, the cellular gatekeeper for growth and division | Q27860990 | ||
WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes | Q28141639 | ||
Tumor suppression by Ink4a-Arf: progress and puzzles | Q28207959 | ||
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 | Q28266637 | ||
T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation | Q28272069 | ||
Cancer cell cycles | Q29547756 | ||
Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation | Q29618286 | ||
The ARF/p53 pathway | Q33840421 | ||
Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival | Q34786830 | ||
Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome | Q36348858 | ||
Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation | Q36352548 | ||
CD43 interferes with T-lymphocyte adhesion | Q37039323 | ||
Adhesion via CD43 induces Syk activation and cell proliferation in TF-1 cells | Q40775700 | ||
Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin | Q40859019 | ||
The cat and mouse games that genes, viruses, and cells play | Q41367391 | ||
Keeping an old friend under control: regulation of p53 stability | Q47786180 | ||
p14ARF links the tumour suppressors RB and p53. | Q55067966 | ||
p19ARF links the tumour suppressor p53 to Ras | Q57562848 | ||
Colon adenoma and cancer cells aberrantly express the leukocyte-associated sialoglycoprotein CD43 | Q73703161 | ||
Tumour associated mutants of p53 can inhibit transcriptional activity of p53 without heterooligomerization | Q77540498 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | 2523-2530 | |
P577 | publication date | 2004-04-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF. | |
P478 | volume | 23 |
Q39411149 | An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes. |
Q40076969 | CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF. |
Q35049278 | CD43 promotes cells transformation by preventing merlin-mediated contact inhibition of growth |
Q35430828 | Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders |
Q35207723 | Common polymorphisms in the CD43 gene region are associated with tuberculosis disease and mortality |
Search more.